Guidelines for reporting pediatric and child health clinical trial protocols and reports: study protocol for SPIRIT-Children and CONSORT-Children

Ami Baba,Maureen Smith,Beth K. Potter,An-Wen Chan,David Moher,Martin Offringa
DOI: https://doi.org/10.1186/s13063-024-07948-7
IF: 2.728
2024-02-01
Trials
Abstract:Despite the critical importance of clinical trials to provide evidence about the effects of intervention for children and youth, a paucity of published high-quality pediatric clinical trials persists. Sub-optimal reporting of key trial elements necessary to critically appraise and synthesize findings is prevalent. To harmonize and provide guidance for reporting in pediatric controlled clinical trial protocols and reports, reporting guideline extensions to the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) and Consolidated Standards of Reporting Trials (CONSORT) guidelines specific to pediatrics are being developed: SPIRIT-Children (SPIRIT-C) and CONSORT-Children (CONSORT-C).
medicine, research & experimental
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is the deficiencies in current pediatric clinical trial reports, especially the lack of key elements, which makes it difficult to comprehensively evaluate, replicate, and synthesize research results. Specifically: 1. **Lack of high - quality pediatric clinical trials**: Although clinical trials in children and adolescents are crucial for providing evidence of the effectiveness of interventions, the number of high - quality pediatric clinical trials is still insufficient. 2. **Inadequate reporting**: In existing pediatric clinical trial reports, key information is often missing, such as the conduct of systematic reviews, detailed descriptions of primary outcome measures, outcome measures related to children's age and development, properties of measurement tools, descriptions of control - group interventions, and social determinants (such as race, gender identity, etc.). 3. **Lack of specialized reporting standards**: As of 2023, there are no reporting standards specifically designed for pediatric clinical trials, which further exacerbates the problem of inadequate reporting. To address these challenges, the paper proposes the goal of developing extended versions of the **SPIRIT - Children (SPIRIT - C)** and **CONSORT - Children (CONSORT - C)** reporting guidelines. These guidelines will: - **Be consistent with the updated SPIRIT/CONSORT 2023 guidelines**, while taking into account the latest developments in the field of pediatric clinical trials. - **Involve a diverse group of partners**, including young people, family caregivers, and global experts, to ensure that reporting items can provide the necessary background information so that readers can correctly interpret, replicate, and synthesize the results of pediatric trials. - **Promote transparency and reduce research waste**, by improving the comprehensiveness and quality of reporting, improving the transparency of pediatric clinical trials, and thus reducing the waste of research resources. In summary, this paper aims to improve the quality and transparency of pediatric clinical trial reports by developing and promoting reporting guidelines specifically for pediatric clinical trials, thereby better supporting clinical decision - making and patient care.